Completed
Ocrelizumab (Ocrevus®)
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
Review of Pharmacotherapy in Multiple Sclerosis - July 26, 2023
Automatically move to the next video in the Classroom when playback concludes
- 1 Intro
- 2 Objectives
- 3 Goal of Disease Modifying Therapy (DMT)
- 4 Factors that impact patient's DMT choice
- 5 Interferons
- 6 Glatiramer acetate
- 7 Monomethyl Fumarate Pro-Drugs
- 8 Sphingosine 1 Phosphate Receptor Modulators
- 9 Teriflunomide (Aubagio®)
- 10 Cladribine (MavencladⓇ)
- 11 Natalizumab (Tysabri®)
- 12 Ocrelizumab (Ocrevus®)
- 13 Ofatumumab (Kesimpta®)
- 14 Alemtuzumab (Lemtrada®)
- 15 Inpatient admission
- 16 Infections and Vaccination
- 17 Malignancy
- 18 Summary
